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Summary
Objectives:  To  assess  predictive  factors  for  deafness  and  facial  palsy  after  vestibular  schwan-
noma surgery  on  a  translabyrinthine  or  retrolabyrinthine  approach,  and  to  compare  sequela
results to  those  for  gamma  knife  radiosurgery.
Patients  and  methods:  A  retrospective  study  included  70  patients  operated  on  for  stage  II
vestibular schwannoma  (Koos  classiﬁcation).  Postoperative  hearing  was  assessed  on  pure-tone
average and  speech  discrimination  score,  and  facial  palsy  on  the  House  and  Brackmann  classi-
ﬁcation, preoperatively  and  at  1  year  postoperatively.  Various  predictive  factors  were  assessed
for both.  Statistical  analysis  used  the  Fischer  exact  test,  with  a  signiﬁcance  threshold  of  P  <  0.05.
Results: Hearing  was  conserved  in  18.9%  of  patients  operated  on  with  a  retrolabyrinthine
approach,  with  8.1%  conserving  useful  hearing.  Facial  function  was  conserved  in  91.4%.  Predic-
tive factors  for  hearing  conservation  did  not  achieve  statistical  signiﬁcance,  but  showed  trends
for: preoperative  pure-tone  average  threshold  ≤  30  dB  and  speech  discrimination  score  ≥  70%,
age less  than  55  years,  tinnitus,  nearly  normal  auditory  brainstem  response  (ABR)  latency,  and
homogeneous  tumor  on  MRI.  Predictive  factors  for  conserved  facial  function  likewise  did  not
achieve statistical  signiﬁcance,  but  showed  trends  for:  age  less  than  55  years,  deafness  of  pro-
gressive onset,  absence  of  cardiovascular  risk  factors,  nearly  normal  ABR  latency  and  tumor
size <  13.5  mm  on  MRI.
Conclusion:  Facial  nerve  risk  is  largely  the  same  with  surgery  or  gamma  knife  radiosurgery.
Concerning  hearing,  gamma  knife  radiosurgery  seems  to  provide  better  hearing  conservation,
but only  over  the  short  term.
© 2012  Published  by  Elsevier  Masson  SAS.∗ Corresponding author. Tel.: +3 35 56 79 56 09.
E-mail address: valerie.vidal@chu-bordeaux.fr
(V. Franco-Vidal).
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doi:10.1016/j.anorl.2011.09.001ntroductionestibular  schwannoma  (or  acoustic  neurinoma)  is  increas-
ngly  diagnosed.  This  can  be  explained  by  more  widespread
RI  access  and  increasingly  precise  imagery.  The  question
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rising  is  that  of  management.  Options  are  many,  from  sim-
le  surveillance  to  a  variety  of  surgical  techniques,  via
amma  knife  radiosurgery  and  fractionated  radiation  ther-
py.  In  France,  small  (stage  I)  tumors  are  generally  managed
y  surveillance  if  symptomatology  is  mild,  as  their  evolution
s  usually  very  slow.  Large  (stage  III  or  IV)  tumors  more  often
ead  to  surgery,  given  the  acute  complications  related  to
arly  edema  associated  with  radiation  therapy.
There  remains  the  question  of  stage  II  tumors,  for  which
here  is  no  consensus  as  to  indications  for  surgery  versus
amma  knife  radiosurgery.  They  are  increasingly  encoun-
ered,  whether  diagnosed  at  that  stage  and  continuing  to
rogress  or  as  stage  I  tumors  increasing  in  volume  under
urveillance.  Moreover,  hearing  and  facial  function  conser-
ation  has  become  a  critical  issue  now  that  surgical  mortality
as  greatly  diminished.
First  described  by  Darrouzet  et  al.  [1],  the  retro-
abyrinthine  approach  is  the  most  recent  otoneurosurgical
pproach,  performed  in  very  few  centers.  It  has  all  the
dvantages  of  transpetrosal  approaches,  but  with  the  addi-
ional  possibility  of  conserving  auditory  function.  Gamma
nife  radiosurgery,  developed  relatively  recently,  has  the
peciﬁcity  of  elevated  topographic  selectivity,  enabling
-step  treatment  with  a  low  marginal  dose  that  spares  adja-
ent  healthy  tissue.
The  present  study  therefore  sought  predictive  factors  for
earing  loss  and  facial,  palsy  secondary  to  translabyrinthine
r  retrolabyrinthine  surgery  in  our  department.  Results  in
erms  of  these  sequelae  were  also  compared  to  those  for
amma  knife  radiosurgery  found  in  the  literature.
atients and methods
 retrospective  study  was  made  of  the  ﬁles  of  70  patients
perated  on  for  stage  II  vestibular  schwannoma  (Koos  clas-
iﬁcation)  between  March  2000  and  June  2008:  36  male,  34
emale;  aged  33  to  73  years  (mean,  55.6  yrs).  In  34  cases
he  tumor  was  on  the  right  side  and  in  36  on  the  left.
urgical  approaches  were  translabyrinthine  (n  =  33)  or  retro-
abyrinthine  (n  =  37).  A  translabyrinthine  approach  was  used
hen  hearing  function  was  deemed  non-useful  and  a retro-
abyrinthine  approach  in  patients  with  useful  preoperative
earing,  and  usually  when  the  tumor  did  not  extend  to
he  fundus  of  the  internal  auditory  canal  (IAC),  which  is
ifﬁcult  to  control  on  a  retrolabyrinthine  approach.  Peroper-
tive  facial  nerve  monitoring  (NIM  nerve  monitoring  system)
as  systematic.  Tumor  resection  was  total  in  all  cases.  One
ase  of  cochlear  nerve  neurinoma  and  all  patients  with
ype-2  neuroﬁbromatosis  were  excluded  from  the  study;  70
atients  were  included.
Study  variables  were:  postoperative  hearing  at  1  year,
nd  presence  and  severity  of  postoperative  facial  palsy  at
 year.  Possible  preoperative  predictive  factors  for  postop-
rative  hearing  loss  or  facial  palsy  that  were  studied  were:
ge,  preoperative  hearing  parameters  (hearing  thresholds,
ype  of  deafness  (progressive,  ﬂuctuating  or  sudden),  and
innitus),  and  history  (diabetes,  cardiac  factors  (angina  or
cute  coronary  syndrome,  and  minor  cardiovascular  risk  fac-
ors:  smoking,  high  blood  pressure,  hypercholesterolemia)).
uditory  brainstem  response  (ABR)  (wave  V  latency  and
nteraural  wave  V  latency  difference)  and  schwannoma
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arameters  on  MRI  (size  (maximal  diameter),  homogeneous
spect  versus  heterogeneity  with  islands  of  necrosis  not
nhanced  by  contrast  medium)  were  also  studied.  IAC
enetration  grade  on  MRI  was  assessed  on  the  Darrouzet
lassiﬁcation  [1]:  grade  1,  tumor  occupying  less  than  half
he  length  of  the  IAC;  grade  2,  tumor  occupying  more  than
alf  the  length  of  the  IAC,  but  sparing  the  fundus;  grade
,  tumor  occupying  the  entire  cochlear  recess  including  the
undus.
Statistical  analysis  used  the  Fisher  test,  with  the  sig-
iﬁcance  threshold  set  at  P  <  0.05.  Hearing  was  assessed
y  mean  pure-tone  audiometry  (PTA)  loss  at  500,  1000,
000  and  4000  Hz  and  speech  discrimination  score  (per-
entage  understood  words  at  35  dB  above  the  intelligibility
hreshold)  for  2-syllable  word-lists.  Useful  hearing  was
eﬁned  by  a  mean  PTA  threshold  ≤  50  dB  and  a  discrimina-
ion  score  ≥  50%,  and  correctable  hearing  as  a  mean  PTA
hreshold  of  51—90  dB  with  discrimination  score  5—49%.
earing  was  considered  conserved  if  useful  or  correctable.
acial  function  was  assessed  on  the  House  and  Brackmann
lassiﬁcation.
esults
earing  was  conserved  in  18.9%  of  cases  (7/37)  after  a
etrolabyrinthine  approach.  Three  of  the  37  patients  (8.1%)
onserved  ‘‘useful’’  hearing.
Facial  function  I  was  conserved  in  91.4%  of  cases  (64/70);
ve  patients  had  grade  III  and  one  grade  IV  facial  palsy  at
 year.
earing  conservation
here  were  no  signiﬁcantly  predictive  factors  for  hear-
ng  conservation.  There  were,  however,  some  trends
Table  1).
23.5%  of  conserved  hearing,  versus  15%  of  over-
5  year-olds.  Progressive  hearing  loss  showed  slightly  better
rognosis  than  sudden  or  ﬂuctuating  hearing  loss.  Hear-
ng  was  conserved  in  26%  of  patients  with  tinnitus.
bsence  of  minor  cardiovascular  risk  factors  showed  a
rend  toward  slightly  better  prognosis.  None  of  the  patients
n  this  series  were  diabetic  or  with  history  of  heart
athology.
Nearly  normal  ABR  wave  V  latency  and  interaural  wave  V
atency  difference  tended  to  be  favorable:  31%  of  patients
ith  wave  V  latency  <  6.60  ms  and  30.8%  of  those  with  inter-
ural  wave  V  latency  difference  <  0.9  did  not  show  total
eafness.  Tumor  size  did  not  show  the  kind  of  impact  that
ight  be  expected:  hearing  was  conserved  in  half  of  those
ith  grade  3  IAC  penetration.  On  the  other  hand,  no  patients
ith  heterogeneous  tumor  on  MRI  were  able  to  conserve
earing.
The  better  the  preoperative  hearing,  the  better  the
hances  of  conservation.  75%  of  patients  with  preoperative
TA  threshold  ≤  30  dB  and  discrimination  score  ≥  70%  showed
seful  postoperative  hearing,  whereas  none  of  those  with
oorer  preoperative  hearing  did  so.
Stage  II  vestibular  schwannoma  89
Table  1  Probability  of  conserving  useful  or  correctable  hearing  according  to  various  factors.
Factor  Hearing  conservation
(%)
Factor  Hearing  conservation
(%)
P
PTA  threshold  ≤  30  dB  and
discrimination
score  ≥  70%
26.7  PTA  thresh-
old  >  30  dB  and
discrimination
score  <  70%
13.6  0.4
Age <  55  yrs  23.5  Age  >  55  yrs  15  0.67
Progressive hearing  loss 20  Non-
progressive
hearing  loss
14  1
Absence of  tinnitus  0  Tinnitus  26  0.15
CVRF-free 17.6  CVRF  11.5  1
Wave V  <  6.6  ms  31  Wave  V  >  6.6  ms
or ABR  non-
interpretable
8.3  0.21
ILD V  <  0.9  ms  30.8  ILD  V  >  0.9  ms  15.4  0.64
Tumor size  <  13.5  mm  18.8  Tumor
size  >  13.5  mm
36.3  0.39
Grade 1  or  2a 14.8  Grade  3a 50  0.09
Homogeneous  35.3  Heterogeneous  0  0.14
CVRF: minor cardiovascular risk factors (smoking, high blood pressure, hypercholesterolemia); ILD V: interaural wave V latency difference;
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a Grade: internal auditory canal (IAC) penetration grade.
Facial  function  conservation
There  were  no  signiﬁcantly  predictive  factors  for  facial
function  conservation.  There  were,  however,  some  trends
(Table  2).
Young  age  showed  a  trend  to  favor  facial  function  conser-
vation,  as  did  progressive  hearing  loss  onset  and  absence  of
minor  cardiovascular  risk  factors.  On  ABR,  increased  wave
V  latency  and  interaural  differential  showed  trends  to  pre-
dict  postoperative  palsy.  Facial  function  was  conserved  in
all  patients  with  maximal  tumor  diameter  <  13.5  mm.  Tumor
grade  and  homogeneity/heterogeneity  seemed  to  be  with-
out  impact.
Only  two  patients  with  facial  palsy  were  free  of  minor
cardiovascular  risk  factors,  which  were  present  in  all  the
others,  and  notably  in  four  patients  with  grade  2  palsy  at
1  year.
Discussion
Study  aims
We  focused  on  stage  II  vestibular  schwannoma,  as  the  choice
between  surgery  and  gamma  knife  radiosurgery  is  espe-
cially  delicate  here;  we  also  wanted  to  determine  potential
conservation  of  hearing  and  facial  function  on  the  two  sur-
gical  techniques  employed  in  our  department.  We  further
sought  predictive  factors  among  the  preoperative  data  avail-
able  for  optimal  conservation  of  these  two  functions  which
are  so  important  for  quality  of  life.  We  therefore  analyzed
the  ﬁles  of  the  70  patients  operated  on  for  stage  II  vestibular
schwannoma  between  2000  and  2008.
1
o
h
sThe  following  discussion  will  examine  published  results
or  hearing  and  facial  function  conservation  with  gamma
nife  radiosurgery  and  try  to  determine  predictive  factors  so
s  better  to  differentiate  indications  between  our  surgical
pproaches  versus  gamma  knife  radiosurgery.
earing  conservation
etrolabyrinthine  surgery  provided  18.9%  hearing  conserva-
ion  and  8.1%  useful  hearing.  We  retrieved  a  large  number  of
tudies  of  conservation  rates  with  gamma  knife  radiosurgery,
ainly  for  small  series,  and  therefore  focused  rather  on
he  meta-analyses  and  recent  literature  reviews  presented
n  Table  3,  so  as  to  get  a general  picture  of  gamma  knife
adiosurgery’s  potential.
It emerged  that  results  were  highly  variable,  ranging
rom  11  to  89%  conservation.  This  was  all  the  more  disturb-
ng  as  the  procedure  is  very  much  automated,  in  contrast
o  surgery.  The  more  recent  results  are  the  best,  thanks
o  the  reduction  in  radiation  dose  over  recent  years.  The
ariability,  however,  is  probably  related  to  pretreatment
uditory  system  status,  which  inﬂuences  radiation  resis-
ance  independently  of  the  procedural  technique.  Results  at
rst  glance  appear  better  than  with  surgery  (18.9%  conser-
ation  in  the  present  series),  but  there  is  a  question  as  to
he  long-term  evolution  of  hearing  following  gamma  knife
adiosurgery,  given  the  sometimes  late  negative  effect  of
adiation.  Thus  Chopra  et  al.  [2],  in  a  series  of  216  patients
reated  by  gamma  knife  radiosurgery  with  marginal  doses  of
2-13  Gy,  reported  71%  hearing  conservation  at  3  years  but
nly  44%  at  10  years,  and  stressed  long-term  impairment  of
earing  following  gamma  knife  radiosurgery.  The  hypothe-
es  to  account  for  this  are:  direct  radiation  effects  on  the
90  S.  Milhe  de  Saint  Victor  et  al.
Table  2  Probability  of  conserving  facial  function  according  to  various  factors.
Factor  Facial  function
conservation  (%)
Factor  Facial  function
conservation  (%)
P
Age  <  55  yrs 96.6  Age  ≥  55  yrs  85.7  0.38
Progressive hearing  loss  92.9  Non-progressive
hearing  loss
85.7  0.59
CVRF-free 93.8  CVRF  88.2  0.67
Wave V  <  6.6  ms 95.5 Wave  V  >  6.6  ms  or
ABR
non-interpretable
90.5  0.65
ILD V  <  0.9  100  ILD  V  >  0.9  85  0.23
Tumor size  <  13.5  mm  100  Tumor  size  >  13.5  mm  85  0.11
Grade 1  or  2a 91.9  Grade  3a 92.3  1
Homogeneous  89  Heterogeneous  87.5  1
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a Grade: internal auditory canal (IAC) penetration grade.
uditory  system,  and  on  the  cochlea  in  particular;  reduced
uditory  system  blood  ﬂow  due  to  vessel  hyalinization;  and
ncreased  IAC  tumor  volume.
On  the  relatively  small  present  series,  no  signiﬁcant
redictive  factors  for  hearing  conservation  emerged,  but
ertain  interesting  trends  were  found.  Favorable  factors
or  hearing  conservation  on  a  retrolabyrinthine  approach
ere:  preoperative  PTA  threshold  ≤  30  dB  and  discrimina-
ion  score  ≥  70%,  age  <  55  years,  tinnitus,  nearly  normal  ABR
atency,  and  homogeneous  tumor  on  MRI.  Patients  with  tin-
itus  had  probably  been  identiﬁed  earlier,  introducing  a
ias.  MRI  is  of  interest  in  case  of  unilateral  tinnitus.  Hear-
ng  was  conserved  in  half  of  grade  3  tumor  patients:  the
etrolabyrinthine  approach  was  tried  in  such  cases  where
er-operative  hearing  was  very  good  despite  tumor  pene-
ration  involving  the  IAC  fundus.
Other  studies  investigated  predictive  factors  for  hearing
onservation  following  surgery  on  a  middle  fossa  or  retrosig-
oid  but  never  a  retrolabyrinthine  approach.  Tumor  size
as  often  reported  as  a  predictive  factor  [3—7], but  these
tudies  concerned  schwannomas  of  all  stages,  whereas  we
w
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Table  3  Hearing  and  facial  function  conservation  following  gamm
Meta-analysis/literature  review  Hearing  conserv
Rutherford  and  King  (2005)  [23]  33  to  79%a
≈  75%  in  most  r
Myrseth et  al.  (2007)  [24]  50  to  89%b
Yang et  al.  (2009)  [10,18]  11  to  77%c
Mean  57%
50  to  70%  in  mo
series
Bhandare et  al.  (2010)  [25]  22  to  74%d
a Variation in deﬁnition of hearing conservation between studies.
b Gardner and Robertson class I, II or III.
c Gardner and Robertson class I or II.
d Gardner and Robertson class I, II, III or IV.
e House and Brackmann grade I or II.ypercholesterolemia); ILD V: interaural wave V latency difference.
ocused  on  stage  II.  Preoperative  hearing  quality  seemed
o  be  a  predictive  factor  for  conservation  [3—6,8]. The
mpact  of  age  and  ABR  latency  varied  from  study  to  study
3,4,8,9].
Turning  to  predictive  factors  for  hearing  conservation
fter  gamma  knife  radiosurgery,  Yang  et  al.  [10]  found  no  sig-
iﬁcant  impact  of  age  or  tumor  size  in  5825  patients  from  74
eports.  In  recent  studies,  favorable  factors  were:  Gardner
nd  Robertson  class  I preoperative  hearing  [11—13], young
ge  [12—14], presenting  symptoms  (notably  tinnitus)  over
nd  above  hearing  impairment  [12—14], normal  ABR  [11],
nd  low-grade  IAC  penetration.
Common  factors  are  thus  primarily  preoperative  hearing
uality  as  indicating  optimal  chances  of  conserving  hearing
fter  gamma-knife  radiosurgery  or  classical  surgery;  age  and
early  normal  ABR  also  appear  to  be  signiﬁcant,  although
ot  conﬁrmed  in  all  studies.  There  is  no  evidence  in  the  lit-
rature  regarding  cardiovascular  risk  factors  as  predictive,
hether  following  classical  surgery  or  gamma  knife  radio-
urgery,  and  tumor  size  in  stage  II  schwannoma  does  not
eem  to  be  inﬂuential.
a  knife  radiosurgery  in  the  literature.
ation  Facial  function
conservatione
ecent  series
95  to  99%
96  to  99%
st  recent
55  to  100%
Mean  96.2%
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Facial  function  conservation
Translabyrinthine  and  retrolabyrinthine  surgery  provided
91.4%  facial  function  conservation.  Facial  palsy  was  deﬁned
as  House  and  Brackmann  grade  III  or  more,  with  grade  II
counted  alongside  grade  I  as  in  the  literature.  Comparison
with  gamma  knife  radiosurgery  was  based  on  the  recent
meta-analyses  and  reviews  (Table  3).  Results  were  fairly
variable,  but  with  more  than  95%  conservation  overall.
This  was  slightly  better  than  with  our  surgical  techniques,
although  it  could  also  be  said  that  facial  function  is  con-
served  in  more  than  90%  of  cases  whatever  the  technique—a
much  more  satisfactory  ﬁgure  than  for  hearing  conservation.
There  were  no  signiﬁcant  predictive  factors  for  facial
function  conservation,  but  there  were  certain  interesting
trends.  Favorable  factors  for  facial  function  conservation  on
a  trans-  or  retrolabyrinthine  approach  were:  age  <  55  years,
progressive  hearing  loss,  absence  of  cardiovascular  risk  fac-
tors,  nearly  normal  ABR  latency,  and  tumor  size  <  13.5  mm.
Tumor  grade  did  not  seem  to  inﬂuence  facial  palsy,  prob-
ably  because  grade  3  tumors  were  usually  managed  by  a
translabyrinthine  approach,  facilitating  facial  nerve  dissec-
tion  within  the  IAC.  Only  two  patients  free  of  cardiovascular
risk  factors  showed  facial  palsy  at  1  year,  versus  eight  with
risk  factors,  including  four  with  grade  2  tumor;  this  suggests
that  patients  with  cardiovascular  risk  factors  take  longer  to
recover  from  facial  palsy.
Other  studies  investigated  predictive  factors  for  hear-
ing  conservation  following  surgery  on  a  translabyrinthine,
retrosigmoid  or  middle  fossa  approach.  Tumor  size  system-
atically  emerged  in  studies  of  vestibular  schwannoma  of  all
grades  taken  together  [4,5,15,16]: it  is  now  consensual  that
facial  nerve  risk  increases  with  tumor  stage.  A  study  of  stage
II  tumors  managed  with  a  retrosigmoid  approach,  however,
found  no  signiﬁcant  impact  of  tumor  size  [17]. The  role
of  age  varied  according  to  the  study  [16,17].  Certain  stud-
ies  reported  other  predictive  factors:  preoperative  hearing
quality  [16], short  clinical  symptom  duration  [16,17],  nearly
normal  ABR  latency  [16,17],  homogeneous  tumor  [15,16],
and  wide  angle  between  tumor  and  IAC  [15,16].
Turning  to  predictive  factors  for  facial  function  conser-
vation  after  gamma  knife  radiosurgery,  Yang  et  al.  [18], in
a  series  of  2204  patients  from  23  reports,  found  a  signif-
icant  impact  of  age  and  tumor  size.  We  were  not  able  to
retrieve  any  other  studies  of  predictive  factors  for  facial
function  conservation  after  gamma  knife  radiosurgery.  Thus,
young  age  and  small  tumor  size  seem  to  favor  facial  func-
tion  conservation,  whether  following  surgery  or  gamma  knife
radiosurgery.  We  were  not  able  to  retrieve  any  data  on  the
impact  of  cardiovascular  risk  factors  on  facial  function  fol-
lowing  surgery  or  gamma  knife  radiosurgery.
Other  drawbacks  of  the  various  treatment  attitudes
The  issue  of  vertigo  secondary  to  gamma  knife  radiosurgery
is  signiﬁcant  for  patients’  quality  of  life,  and  is  currently  a
matter  of  debate.  Two  studies  [19,20]  reported  13%  [19]  and
27%  [20]  vertigo  onset  rates  secondary  to  gamma  knife  radio-
surgery  and  a  6%  rate  of  disappearance  of  vertigo,  with  the
remaining  patients  showing  persistent  vertigo.  Gamma  knife
radiosurgery  fails  to  allow  central  vestibular  compensation.91
he evolution  of  vestibular  disorder  was  not  analyzed  in  the
resent  series,  as  we  do  not  routinely  perform  postoperative
ideonystagmography;  a  further  study  will  be  needed,  and
s  currently  underway  in  our  department.
Finally,  follow-up  duration  is  a  key  element,  whichever
he  treatment  option.  For  gamma  knife  radiosurgery,  results
ppear  only  at  3  years  and  intermediate  reports  are  of
ittle  value.  The  risk  of  malignant  evolution,  while  low
at  <  1/1000)  is  real  [21]. Surgery  involves  a  risk  of  recur-
ence  as  high  as  10%  [22], seen  on  regular  MRI  surveillance
ver  several  years.  Recurrence  develops  from  small  frag-
ents  unintentionally  left  after  surgery;  patients  will  not
ecessarily  experience  heavy  symptoms,  however,  and  may
ot  always  need  treatment.
onclusion
amma  knife  radiosurgery  shows  better  conservation  of
earing,  but  over  the  short  term.  Facial  nerve  risk  is  much
he  same  between  surgery  and  gamma  knife  radiosurgery.
he  main  predictive  factors  for  hearing  conservation  are
ood  preoperative  hearing,  young  age,  and  short  ABR
atency.  For  facial  function  conservation,  they  are  young
ge  and  small  tumor  size.  The  present  study  did  not  ﬁnd
ne  technique  to  be  preferable  to  the  other;  nevertheless,
he  risk  of  malignant  transformation  following  gamma  knife
adiosurgery  in  young  patients  is  to  be  borne  in  mind.  Clear
nd  objective  information  should  be  given  to  the  patient,
ho  has  the  ﬁnal  choice.
isclosure of interest
he  authors  declare  that  they  have  no  conﬂicts  of  interest
oncerning  this  article.
eferences
[1] Darrouzet V, Guérin J, Aouad N, et al. The widened retro-
labyrinthine approach: a new concept in acoustic neuroma
surgery. J Neurosurg 1997;86:812—21.
[2] Chopra R, Kondziolka D, Niranjan A, et al. Long-term
follow-up of acoustic schwannoma radiosurgery with marginal
tumor doses of 12 to 13 Gy. Int J Radiat Oncol Biol Phys
2007;68:845—51.
[3] Rohit, Piccirillo E, Jain Y, et al. Preoperative predictive factors
for hearing preservation in vestibular schwannoma surgery. Ann
Otol Rhinol Laryngol 2006;115:41—6.
[4] Samii M, Gerganov V, Samii A. Improved preservation of hear-
ing and facial nerve function in vestibular schwannoma surgery
via the retrosigmoid approach in a series of 200 patients. J
Neurosurg 2006;105:527—35.
[5] Meyer TA, Canty PA, Wilkinson EP, et al. Small acoustic neuro-
mas: surgical outcomes versus observation or radiation. Otol
Neurotol 2006;27:380—92.
[6] Yang J, Grayeli AB, Barylyak R, et al. Functional outcome of
retrosigmoid approach in vestibular schwannoma surgery. Acta
Otolaryngol 2008;128:881—6.
[7] Gjuric M, Mitrecic MZ, Greess H, et al. Vestibular schwannoma
volume as a predictor of hearing outcome after surgery. Otol
Neurotol 2007;28:822—7.
[8] Brackmann DE, Owens RM, Friedman RA, et al. Prognostic fac-
tors for hearing preservation in vestibular schwannoma surgery.
Am J Otol 2000;21:417—24.
9[
[
[
[
[
[
[
[
[
[
[
[
[
[
[2  
[9] Fenton JE, Chin RY, Fagan PA, et al. Predictive factors of
long-term facial nerve function after vestibular schwannoma
surgery. Otol Neurotol 2002;23:388—92.
10] Yang I, Aranda D, Han SJ, et al. Hearing preservation after
stereotactic radiosurgery for vestibular schwannoma: a sys-
tematic review. J Clin Neurosci 2009;16:742—7.
11] Kim CH, Chung KW, Kong DS, et al. Prognostic factors of hear-
ing preservation after gamma knife radiosurgery for vestibular
schwannoma. J Clin Neurosci 2010;17(2):214—8.
12] Kano H, Kondziolka D, Khan A, et al. Predictors of hearing
preservation after stereotactic radiosurgery for acoustic neu-
roma. J Neurosurg 2009;111:863—73.
13] Régis J, Tamura M, Delsanti C, et al. Hearing preservation in
patients with unilateral vestibular schwannoma after gamma
knife surgery. Prog Neurol Surg 2008;21:142—51.
14] Tamura M, Carron R, Yomo S, et al. Hearing preservation after
gamma knife radiosurgery for vestibular schwannomas present-
ing with high-level hearing. Neurosugery 2009;64:289—96.
15] Deguine O, Maillard A, Bonafe A, et al. Preoperative and per-
operative factors conditioning long-term facial nerve function
in vestibular schwannoma surgery through translabyrinthine
approach. J Laryngol Otol 1998;112:441—5.
16] Zaouche S, Ionescu E, Dubreuil C, Ferber-Viart C. Pre- and
intraoperative predictive factors of facial palsy in vestibular
schwannoma surgery. Acta Otolaryngol 2005;125—4:363—9.
17] Bouchene M, Pavillon S, Zaouche S, et al. Facteurs pré-
dictifs de la survenue des paralysies faciales du neurinome
[S.  Milhe  de  Saint  Victor  et  al.
de l’acoustique opéré par voie rétro-sigmoïde. À propos de
230 cas. Ann Otolaryngol Chir Cervicofac 2006;123:319—24.
18] Yang I, Sughrue ME, Han SJ, et al. Facial nerve preserva-
tion after vestibular schwannoma Gamma Knife Radiosurgery.
J Neurooncol 2009;93:41—8.
19] Hempel JM, Hempel E, Wowra B, et al. Functional outcome
after gamma knife treatment in vestibular schwannoma. Eur
Arch Otorhinolaryngol 2006;263:714—8.
20] Wackym PA, Hannley MT, Runge-Samuelson CL, et al. Gamma
Knife surgery of vestibular schwannomas: longitudinal changes
in vestibular function and measurement of the Dizziness Hand-
icap Inventory. J Neurosurg 2008;119(Suppl.):137—43.
21] Akamatsu Y, Murakami K, Watanabe M, et al. Malignant
peripheral nerve sheath tumor arising from benign vestibular
schwannoma treated by gamma knife radiosurgery after two
previous surgeries: a case report with surgical and pathological
observations. World Neurosurg 2010;73:751—4.
22] Roche PH, Ribeiro T, Khalil M, et al. Recurrence of vestibular
schwannomas after surgery. Prog Neurol Surg 2008;21:89—92.
23] Rutherford SA, King AT. Vestibular schwannoma management:
what is the best option? Br J Neurosurg 2005;19:309—16.
24] Myrseth E, Pedersen PH, Moller P, et al. Treatment of
vestibular schwannomas: why, when and how? Acta Neurochir
2007;149:647—60.
25] Bhandare N, Jackson A, Eisbruch A, et al. Radiation therapy
and hearing loss. Int J Radiat Oncol Biol Phys 2010;76(Suppl.
3):S50—7.
